×
For best experience we recommend to activate Javascript in your browser.
Sorting Nexin 3 antibody (AA 1-113)
The Mouse Monoclonal anti-Sorting Nexin 3 antibody is suitable to detect Sorting Nexin 3 in samples from Human. It has been validated for ELISA and WB.
Catalog No. ABIN522170
$442.13
$520.15
save $78.02 (-15 %)
Plus shipping costs $50.00
Delivery in 11 to 12 Business Days
Quick Overview for Sorting Nexin 3 antibody (AA 1-113) (ABIN522170)
Target
See all Sorting Nexin 3 (SNX3) Antibodies
Sorting Nexin 3 (SNX3)
Reactivity
All reactivities for Sorting Nexin 3 antibodies
Human
Host
All hosts for Sorting Nexin 3 antibodies
Mouse
Clonality
All clonalities for Sorting Nexin 3 antibodies
Monoclonal
Conjugate
All conjugates for Sorting Nexin 3 antibodies
This Sorting Nexin 3 antibody is un-conjugated
Application
All applications for Sorting Nexin 3 antibodies
ELISA, Western Blotting (WB)
Clone
3D7
Product Details anti-Sorting Nexin 3 Antibody
(hide)
Binding Specificity
All epitopes for Sorting Nexin 3 antibodies
AA 1-113
Purpose
Mouse monoclonal antibody raised against a full-length recombinant SNX3.
Sequence
MAETVADTRR LITKPQNLND AYGPPSNFLE IDVSNPQTVG VGRGRFTTYE IRVKTNLPIF KLKESTVRRR YSDFEWLRSE LERESKPCLR MTSEARSHGR TWCAQNDEKL FCD
Cross-Reactivity
Human
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
SNX3 (AAH16863, 1 a.a. ~ 113 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Isotype
IgG2a
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Buffer
In 1x PBS, pH 7.4
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Target Details for Sorting Nexin 3
(hide)
Target
Sorting Nexin 3 (SNX3)
Alternative Name
SNX3
Background
Full Gene Name: sorting nexin 3 Synonyms: Grd19,MCOPS8,MGC17570,SDP3,SNX3A
Gene ID
8724
Recently viewed
(hide)
Chat with us , powered by LiveChat